DCM
XBI icon

Davis Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Davis Capital Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.7K Hold
352
– – 0.03% 158
2026
Q1 		$45K Hold
352
– – 0.03% 143
2025
Q4 		$42.9K Hold
352
– – 0.03% 146
2025
Q3 		$35.3K Buy
+352
New +$31.7K 0.02% 162
2025
Q1 		$28.5K Hold
352
– – 0.02% 170
2024
Q4 		$31.7K Hold
352
– – 0.03% 164
2024
Q3 		$34.8K Hold
352
– – 0.03% 165
2024
Q2 		$32.8K Hold
352
– – 0.03% 165
2024
Q1 		$33K Hold
352
– – 0.03% 159
2023
Q4 		$31.4K Buy
+352
New +$26.1K 0.03% 156
2020
Q2 		$39K Hold
352
– – 0.07% 117
2020
Q1 		$27K Buy
+352
New +$31.2K 0.06% 133

Other funds holding XBI

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
MFS
Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return
EWM
Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Davis Capital Management's XBI Position: Q2 2026 in Review

Davis Capital Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 352 shares worth $55.7K. The position accounts for 0.03% of the portfolio, ranked #158.

Davis Capital Management first reported a position in XBI in Q1 2020 and has held it in 12 quarters since. 260 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Davis Capital Management held 352 shares of State Street SPDR S&P Biotech ETF worth $55.7K as of Q2 2026.
  • Davis Capital Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.03% of Davis Capital Management's portfolio in Q2 2026, its #158 holding.
  • Davis Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 12 quarters since.
  • 260 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.